Latest Oncology Drug Development News

Page 2 of 2

Algorae Teams with Peter Mac to Validate AI-Driven Cancer Drug Synergies

Algorae Pharmaceuticals has partnered with Peter MacCallum Cancer Centre to validate AI-predicted drug combinations across multiple cancer types, aiming to accelerate its oncology pipeline development.

Ada Torres

8 May 2025

Amplia Therapeutics Surges Ahead with ACCENT Trial Recruitment Completion

Amplia Therapeutics has completed enrolment for its ACCENT Phase 2a trial in advanced pancreatic cancer two months early, reporting encouraging partial response rates and improved patient outcomes.

Victor Sage

31 Jan 2025